electroCore to Announce Second Quarter Ended June 30, 2020 Financial Results on Thursday, August 13

Rhea-AI Summary

electroCore, Inc. (Nasdaq: ECOR) will announce its financial results for the second quarter ended June 30, 2020, on August 13, 2020, after market close. A conference call will take place at 4:30 PM Eastern Time to discuss the results and address questions. The company, focused on bioelectronic medicine, aims to enhance patient outcomes with its non-invasive vagus nerve stimulation therapy targeting conditions like cluster headaches and migraines.

Positive

• Company's focus on improving patient outcomes in neurology.
• Innovative non-invasive vagus nerve stimulation therapy.

Negative

• None.

BASKING RIDGE, N.J., Aug. 06, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced that it will report financial results for the second quarter ended June 30, 2020 after the close of the market on Thursday, August 13, 2020.  Management will host a conference call and webcast at 4:30pm Eastern Time to discuss the financial results and answer questions.

Thursday, August 13 @ 4:30pm Eastern Time
Domestic:	877-407-4018
International:	201-689-8471
Conference ID:	13706874
Webcast:	http://public.viavid.com/index.php?id=140717

About electroCore, Inc.

electroCore, Inc. is a commercial-stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused on the treatment of multiple conditions in neurology. The company’s current indications are the preventative treatment of cluster headache and migraine and acute treatment of migraine and episodic cluster headache.

For more information, visit www.electrocore.com.

Investors:
Hans Vitzthum
LifeSci Advisors
617-430-7578
hans@lifesciadvisors.com

or

Media Contact:
Jackie Dorsky
electroCore
973-290-0097
jackie.dorsky@electrocore.com

FAQ

What are the financial results for electroCore (ECOR) in Q2 2020?

electroCore will report its Q2 2020 financial results on August 13, 2020.

What is the date of electroCore's Q2 2020 conference call?

The conference call is scheduled for August 13, 2020, at 4:30 PM Eastern Time.

What therapies does electroCore focus on?

electroCore specializes in non-invasive vagus nerve stimulation therapy for cluster headaches and migraines.

How can I access the electroCore Q2 2020 webcast?

The webcast can be accessed at http://public.viavid.com/index.php?id=140717.